Skip to search formSkip to main contentSkip to account menu

Estrogen Agonist/Antagonist [EPC]

Known as: Estrogen Agonist/Antagonist, Selective Estrogen Receptor Modulator, Mixed Estrogen Agonist and Antagonist 
National Institutes of Health

Related topics

Related topics

1 relation
Selective Estrogen Receptor Modulators

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial
The selective estrogen receptor modulator (SERM) tamoxifen has long been used to treat both early and advanced breast cancer… 
Highly Cited
2003
Highly Cited
2003
Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy.
2003
2003
Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal.
2002
2002
Mood effect of raloxifene in postmenopausal women.
Review
2001
Review
2001
The Past, Present, and Future of Selective Estrogen Receptor Modulation
Abstract: The recognition of selective estrogen receptor modulation in the mid‐1980s provided a unique opportunity to develop… 
2001
2001
Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator
This study assessed the effects of raloxifene, a selective estrogen receptor modulator (SERM), on ovarian morphology and… 
2001
2001
Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits.
Highly Cited
2000
Highly Cited
2000
Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats
OBJECTIVE: The estrogen antagonist EM-652.HCl behaves as a highly potent and pure antiestrogen in human breast and uterine cancer… 
Review
1998
Review
1998
Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene.
Multiple health benefits have been postulated for the long-term use of hormone therapy in postmenopausal women, most notably for… 
1996
1996
The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
The MRL lpr/lpr mouse strain is an animal model for the autoimmune disorder systemic lupus erythematosus (SLE). Pathologic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)